Refractory hematologic cancer
MONDO:0004111A hematologic malignancy that is resistant to treatment.
Also known as: refractory hematologic cancer, refractory hematologic malignancy
2139 clinical trials for this condition and its sub-types, 62 tagged with Refractory hematologic cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Refractory hematologic cancer
-
Refractory plasma cell neoplasm 228 trials
-
Refractory hairy cell leukemia 9 trials
-
2 sub-types
-
Refractory cytopenia of childhood 0 trials
-
New drug HEC89736 tested in blood cancer patients – but trial stopped early
Disease control Stopped earlyThis early-phase trial tested an experimental drug called HEC89736 in people with B-cell blood cancers that had returned or stopped responding to treatment. The study aimed to check the drug's safety and how the body processes it. Only 5 people took part before the trial was term…
Phase 1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Radiation after failed CAR t: tiny study halted early
Disease control Stopped earlyThis pilot study looked at whether radiation therapy could help people with lymphoma that did not respond to CAR T cell therapy. Only 3 participants were enrolled before the study was terminated. The main goal was to check safety and side effects of adding radiation shortly after…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC